Inventor · disambiguated record
David Stamler
Also filed as: STAMLER DAVID
6 granted patents·8 pending applications·5 citations·filing 2015–2024
76Inventor score
Files withAUSPEX PHARMACEUTICALS INC14
Top patents by PatentIndex Score
14 records- 0188US10959996B2Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2018·Granted Mar 30, 2021·5 cites·40 claims
- 0287US2024316035A1Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0382US2024307371A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0477US12016858B2Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2021·Granted Jun 25, 2024·0 cites·40 claims
- 0575US11446291B2Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2021·Granted Sep 20, 2022·0 cites·30 claims
- 0674US11357772B2Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2021·Granted Jun 14, 2022·0 cites·44 claims
- 0774US2023122780A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0871US11564917B2Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2017·Granted Jan 31, 2023·0 cites·32 claims
- 0970US11648244B2Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2017·Granted May 16, 2023·0 cites·23 claims
- 1067US2020281917A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1165US2018169087A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1261US2017151227A1Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1359US2016287574A1Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1458US2016346270A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →